Filing Details

Accession Number:
0001237899-12-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-23 16:50:55
Reporting Period:
2012-01-19
Filing Date:
2012-01-23
Accepted Time:
2012-01-23 16:50:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226435 A Murray Goldberg 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Finance And Admin Cfo Trea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-01-19 40,800 $20.32 130,161 No 4 M Direct
Common Stock Disposition 2012-01-19 10,424 $79.53 119,737 No 4 F Direct
Common Stock Disposition 2012-01-19 13,193 $79.53 106,544 No 4 F Direct
Common Stock Disposition 2012-01-20 13,567 $77.86 92,977 No 4 S Direct
Common Stock Disposition 2012-01-20 3,216 $78.17 89,761 No 4 S Direct
Common Stock Disposition 2012-01-20 400 $79.51 89,361 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-01-19 40,800 $0.00 40,800 $20.32
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2012-01-19 10,424 $0.00 10,424 $79.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,279 2016-12-18 No 4 M Direct
10,424 2012-01-19 2016-12-18 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,416 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 13,567 shares of Company stock on January 20, 2012 at prices ranging from $77.51 to $77.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 20, 2012 at each separate price.
  3. Represents volume-weighted average price of sales of 3,216 shares of Company stock on January 20, 2012 at prices ranging from $78.00 to $78.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 20, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 400 shares of Company stock on January 20, 2012 at prices ranging from $79.22 to $79.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 20, 2012 at each separate price.
  5. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  6. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.